497 related articles for article (PubMed ID: 20672848)
21. The epidemiology of myasthenia gravis, Lambert-Eaton myasthenic syndrome and their associated tumours in the northern part of the province of South Holland.
Wirtz PW; Nijnuis MG; Sotodeh M; Willems LN; Brahim JJ; Putter H; Wintzen AR; Verschuuren JJ;
J Neurol; 2003 Jun; 250(6):698-701. PubMed ID: 12796832
[TBL] [Abstract][Full Text] [Related]
22. Altered immunoglobulin G glycosylation in patients with isolated hyperprolactinaemia.
Hirschberg D; Ekman B; Wahlberg J; Landberg E
PLoS One; 2021; 16(2):e0247805. PubMed ID: 33635916
[TBL] [Abstract][Full Text] [Related]
23. Terminal sugars of Fc glycans influence antibody effector functions of IgGs.
Raju TS
Curr Opin Immunol; 2008 Aug; 20(4):471-8. PubMed ID: 18606225
[TBL] [Abstract][Full Text] [Related]
24. A detailed lectin analysis of IgG glycosylation, demonstrating disease specific changes in terminal galactose and N-acetylglucosamine.
Bond A; Alavi A; Axford JS; Bourke BE; Bruckner FE; Kerr MA; Maxwell JD; Tweed KJ; Weldon MJ; Youinou P; Hay FC
J Autoimmun; 1997 Feb; 10(1):77-85. PubMed ID: 9080302
[TBL] [Abstract][Full Text] [Related]
25. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods.
Reusch D; Haberger M; Falck D; Peter B; Maier B; Gassner J; Hook M; Wagner K; Bonnington L; Bulau P; Wuhrer M
MAbs; 2015; 7(4):732-42. PubMed ID: 25996192
[TBL] [Abstract][Full Text] [Related]
26. [Intermittent myasthenic syndrome: combination of myasthenia gravis and myasthenic syndrome of the Lambert-Eaton type].
Sanadze AG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(9):93-7. PubMed ID: 1664626
[TBL] [Abstract][Full Text] [Related]
27. Patients with IgG1-anti-red blood cell autoantibodies show aberrant Fc-glycosylation.
Sonneveld ME; de Haas M; Koeleman C; de Haan N; Zeerleder SS; Ligthart PC; Wuhrer M; van der Schoot CE; Vidarsson G
Sci Rep; 2017 Aug; 7(1):8187. PubMed ID: 28811589
[TBL] [Abstract][Full Text] [Related]
28. A diagnostic and management dilemma: combined paraneoplastic myasthenia gravis and Lambert-Eaton myasthenic syndrome presenting as acute respiratory failure.
Roohi F; Smith PR; Bergman M; Baig MA; Sclar G
Neurologist; 2006 Nov; 12(6):322-6. PubMed ID: 17122730
[TBL] [Abstract][Full Text] [Related]
29. Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity.
Kumpel BM; Rademacher TW; Rook GA; Williams PJ; Wilson IB
Hum Antibodies Hybridomas; 1994; 5(3-4):143-51. PubMed ID: 7756579
[TBL] [Abstract][Full Text] [Related]
30. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse.
Waterman SA; Lang B; Newsom-Davis J
Ann Neurol; 1997 Aug; 42(2):147-56. PubMed ID: 9266723
[TBL] [Abstract][Full Text] [Related]
31. A comprehensive analysis of subclass-specific IgG glycosylation in colorectal cancer progression by nanoLC-MS/MS.
Liu S; Fu Y; Huang Z; Liu Y; Liu BF; Cheng L; Liu X
Analyst; 2020 Apr; 145(8):3136-3147. PubMed ID: 32186558
[TBL] [Abstract][Full Text] [Related]
32. Glycosylation in the Fc domain of IgG increases resistance to proteolytic cleavage by papain.
Raju TS; Scallon BJ
Biochem Biophys Res Commun; 2006 Mar; 341(3):797-803. PubMed ID: 16442075
[TBL] [Abstract][Full Text] [Related]
33. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
Andreis I; Lovnićki TJ; Beara N; Taradi M
Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
[TBL] [Abstract][Full Text] [Related]
34. High-throughput work flow for IgG Fc-glycosylation analysis of biotechnological samples.
Reusch D; Haberger M; Selman MH; Bulau P; Deelder AM; Wuhrer M; Engler N
Anal Biochem; 2013 Jan; 432(2):82-9. PubMed ID: 23026777
[TBL] [Abstract][Full Text] [Related]
35. Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes.
Bondt A; Rombouts Y; Selman MH; Hensbergen PJ; Reiding KR; Hazes JM; Dolhain RJ; Wuhrer M
Mol Cell Proteomics; 2014 Nov; 13(11):3029-39. PubMed ID: 25004930
[TBL] [Abstract][Full Text] [Related]
36. Control of recombinant monoclonal antibody effector functions by Fc N-glycan remodeling in vitro.
Hodoniczky J; Zheng YZ; James DC
Biotechnol Prog; 2005; 21(6):1644-52. PubMed ID: 16321047
[TBL] [Abstract][Full Text] [Related]
37. Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid.
Wuhrer M; Selman MH; McDonnell LA; Kümpfel T; Derfuss T; Khademi M; Olsson T; Hohlfeld R; Meinl E; Krumbholz M
J Neuroinflammation; 2015 Dec; 12():235. PubMed ID: 26683050
[TBL] [Abstract][Full Text] [Related]
38. Effect of IgG immunoadsorption on serum cytokines in MG and LEMS patients.
Baggi F; Ubiali F; Nava S; Nessi V; Andreetta F; Rigamonti A; Maggi L; Mantegazza R; Antozzi C
J Neuroimmunol; 2008 Sep; 201-202():104-10. PubMed ID: 18644634
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Fc N-Glycosylation of Pharmaceutical Products of Intravenous Immunoglobulin G.
Fokkink WJ; Falck D; Santbergen TC; Huizinga R; Wuhrer M; Jacobs BC
PLoS One; 2015; 10(10):e0139828. PubMed ID: 26457892
[TBL] [Abstract][Full Text] [Related]
40. Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination.
Selman MH; de Jong SE; Soonawala D; Kroon FP; Adegnika AA; Deelder AM; Hokke CH; Yazdanbakhsh M; Wuhrer M
Mol Cell Proteomics; 2012 Apr; 11(4):M111.014563. PubMed ID: 22184099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
